Free Trial

InfuSystem (INFU) Competitors

InfuSystem logo
$5.60 +0.38 (+7.28%)
Closing price 04:00 PM Eastern
Extended Trading
$5.60 +0.01 (+0.09%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INFU vs. TMCI, CLPT, OM, NNOX, SMTI, NYXH, STIM, SNWV, ZIMV, and NVRO

Should you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Outset Medical (OM), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Nyxoah (NYXH), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), and Nevro (NVRO). These companies are all part of the "medical equipment" industry.

InfuSystem vs.

InfuSystem (NYSE:INFU) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Treace Medical Concepts received 15 more outperform votes than InfuSystem when rated by MarketBeat users. However, 100.00% of users gave InfuSystem an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote.

CompanyUnderperformOutperform
InfuSystemOutperform Votes
11
100.00%
Underperform Votes
No Votes
Treace Medical ConceptsOutperform Votes
26
44.07%
Underperform Votes
33
55.93%

InfuSystem has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InfuSystem$137.58M0.86$870K$0.1440.00
Treace Medical Concepts$210.82M1.75-$49.53M-$0.85-6.89

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

InfuSystem has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

InfuSystem presently has a consensus price target of $13.00, indicating a potential upside of 132.14%. Treace Medical Concepts has a consensus price target of $10.16, indicating a potential upside of 73.33%. Given InfuSystem's stronger consensus rating and higher possible upside, equities research analysts clearly believe InfuSystem is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InfuSystem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
Treace Medical Concepts
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

InfuSystem has a net margin of 1.12% compared to Treace Medical Concepts' net margin of -30.33%. InfuSystem's return on equity of 2.78% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
InfuSystem1.12% 2.78% 1.41%
Treace Medical Concepts -30.33%-51.12%-26.36%

In the previous week, Treace Medical Concepts had 19 more articles in the media than InfuSystem. MarketBeat recorded 21 mentions for Treace Medical Concepts and 2 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.59 beat Treace Medical Concepts' score of 0.14 indicating that InfuSystem is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InfuSystem
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Treace Medical Concepts
4 Very Positive mention(s)
3 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

InfuSystem beats Treace Medical Concepts on 12 of the 19 factors compared between the two stocks.

Get InfuSystem News Delivered to You Automatically

Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INFU vs. The Competition

MetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$117.69M$4.42B$5.39B$19.46B
Dividend YieldN/A45.22%5.29%3.91%
P/E Ratio93.3529.4027.0334.73
Price / Sales0.8672.62412.3741.78
Price / Cash12.7951.0838.2517.51
Price / Book2.276.196.844.74
Net Income$870,000.00$66.96M$3.22B$1.02B
7 Day Performance-3.45%0.54%2.42%1.52%
1 Month Performance13.82%42.65%10.69%4.94%
1 Year PerformanceN/A27.29%21.00%7.10%

InfuSystem Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INFU
InfuSystem
2.7138 of 5 stars
$5.60
+7.3%
$13.00
+132.1%
N/A$117.69M$137.58M93.35410Positive News
TMCI
Treace Medical Concepts
2.3457 of 5 stars
$5.88
-3.6%
$10.16
+72.7%
+15.8%$369.79M$210.82M-5.94250Trending News
CLPT
ClearPoint Neuro
1.8506 of 5 stars
$11.89
-1.6%
$25.00
+110.3%
+119.4%$332.79M$32.24M-17.23110Gap Down
OM
Outset Medical
2.4931 of 5 stars
$17.95
-2.8%
$27.00
+50.4%
-67.3%$318.11M$115.27M-7.24520Positive News
Short Interest ↓
Gap Up
NNOX
Nano-X Imaging
1.9603 of 5 stars
$5.13
-2.1%
$9.50
+85.2%
-39.3%$296.41M$11.55M-6.04190Earnings Report
Gap Up
SMTI
Sanara MedTech
2.2881 of 5 stars
$30.39
-1.9%
$49.50
+62.9%
-5.4%$270.11M$91.57M-30.7060Short Interest ↓
NYXH
Nyxoah
2.6682 of 5 stars
$7.74
-7.0%
$14.50
+87.3%
-8.2%$263.62M$4.36M-4.14110Gap Up
STIM
Neuronetics
2.8241 of 5 stars
$3.99
flat
$5.50
+37.8%
+85.1%$262.62M$89.45M-3.24180Positive News
Short Interest ↓
SNWV
SANUWAVE Health
N/A$28.55
-1.1%
N/AN/A$244.27M$36.19M-6.2640News Coverage
ZIMV
ZimVie
2.476 of 5 stars
$8.28
-0.8%
$16.33
+97.3%
-46.4%$230.57M$443.55M-0.632,700
NVRO
Nevro
0.2082 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-38.6%$224.32M$408.52M-3.091,090

Related Companies and Tools


This page (NYSE:INFU) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners